Could gene editing offer the one-time fix for artery-clogging cholesterol?
WASHINGTON (AP) — Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that…
Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip.
There are almost always some companies doing well, even when competitors in the same industry are sinking. Right…
Hims & Hers cancels plan for Wegovy weight-loss pill knockoff
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Eli Lilly‘s (NYSE: LLY) stock has risen 225% over the past three years. That trounces the S&P 500‘s (SNPINDEX:…
The most controversial Super Bowl ad of 2025 is back for more
Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process.…
GLP-1 drugs transforming obesity and diabetes care in San Antonio
GLP-1 medications have transformed obesity and weight management care in the U.S. and in San Antonio. And with…
Which Is the Better Stock Buy?
Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified…
Takeaways on turmoil surrounding FDA fast-track drug program
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…